Christine Uekert

Christine Uekert, born in 1964, first studied art history and Italian at the Free University of Berlin. In 2004, she graduated with a degree in business administration from Verwaltungs- und Wirtschaftsakademie Berlin. In 2008 she obtained the CINA Certificate in International Accounting (IFRS, US GAAP) at the Akademie für Internationale Rechnungslegung (Academy for International Accounting), Cologne.

Christine Uekert started her professional career in 2000 as Vice President Finance at SAP SI AG / SPM Technologies GmbH and moved to ProBioGen AG, Berlin, in 2006 as Director Finance & Administration. From 2009 to 2011, she was Vice President Finance and an executive holding a general power of attorney at medical technology company OD-OS GmbH. In 2011, she was appointed CFO of global diagnostics company Centogene AG. Until 2016, Ms. Uekert was responsible for developing the latter company’s financial architecture and expansion strategy, successfully supporting growth that led to a more than tenfold increase in revenue within five years.

In 2016, Christine Uekert founded consulting firm nsight Consulting GmbH in Berlin, within which she has since managed consulting mandates for growing and international technology and biotechnology companies, especially including interim positions as CFO at the listed company Curasan AG and as CSO at genetics startup Arcensus GmbH.

Christine Uekert has been a member of the BRAIN Biotech AG Supervisory Board since March 8, 2023 and is elected until the end of the AGM in FY 2026/27.

Further memberships of statutory Supervisory Boards in Germany:

  • Member of the Supervisory Board of Titanium Textiles AG, Rostock

Further memberships in comparable German and foreign Supervisory Boards:

  • None

Independent within the meaning of Section C.6, C.7 and C.9 of the German Corporate Governance Code:

Yes


Last update: March 2023

Share this page